Category: For Doctors and Researchers

Home / For Doctors and Researchers

Categories

Gene Therapy for Gaucher’s Disease in China

Gene Therapy for Gaucher’s Disease in ChinaGaucher's disease is a rare inherited condition that happens when the body doesn't have enough of the glucocerebrosidase (GBA) enzyme, leading to harmful f...

Gene Therapy for Wilson’s Disease in China

Gene Therapy for Wilson's Disease in China   Introduction Wilson’s disease is a rare genetic disorder that causes excessive copper accumulation in the liver, brain, and other vital organs. With...

Advances in Liver Transplant Surgery: Techniques and Technologies

IntroductionLiver transplant surgery has seen tremendous progress in the last few decades, transforming the therapeutic possibilities of patients with end-stage liver disease, acute liver failure, and...

Enhancing Cancer Outcomes: The Critical Role of Early CAR T-Cell Therapy

Cancer remains one of the most challenging diseases to treat, requiring innovative and effective therapies. One of the most promising advancements in cancer treatment is Chimeric Antigen Receptor (CA...

Personalized T-Cell therapies in the treatment of hematological malignancies

 IntroductionCancer is still one of the most difficult diseases to cure, and conventional treatments such as chemotherapy, radiation, and surgery have yielded limited success and severe side effects....

Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment

 CAR immune Cell therapyChimeric Antigen Receptor (CAR) immune cell therapy has transformed the treatment of cancer, especially for hematological cancers. Its effectiveness notwithstanding, it still ...

How to prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies?

 CAR T Cell therapyChimeric Antigen Receptor (CAR) T-cell therapy has changed the face of treating B-cell malignancies, and it has provided hope to those with relapsed or refractory disease. Through ...

Donor T cells for CAR T cell therapy

 CAR T Cell therapyChimeric Antigen Receptor (CAR) T cell therapy has transformed cancer treatment by genetically modifying a patient's own T cells to target and destroy cancer cells. Although this a...

Strategies to optimize chimeric antigen receptor T-cell therapy in hematologic malignancies: Experience from China

 CAR T Cell therapyChimeric Antigen Receptor (CAR) T-cell therapy has changed the course of treatment for numerous hematologic malignancies like leukemia, lymphoma, and multiple myeloma. China is at ...

CAR T-cell therapies in China: A Journey of Rapid Growth and Promise

The rise of CAR T Cell therapy in ChinaChina's journey with CAR T-cell therapy began in 2013 with the first clinical trials. Since then, the country has witnessed an exponential growth in this field, ...

We Are Online! Chat With Us!
Scan the code